The group’s principal activity is to manufacture pharmaceuticals products for cardiovascular and endocrine diseases. The group's therapeutic areas include neonatology, oncology, endocrinology, and cardiology. The group's products include DIBENZYLINE(R), COLACE(TM) and DYRENIUM(R). The group operates from the United States and Canada.
Executive Information
Name
Title
Email
Robert Vukovich
Chmn., CEO, Pres.
N/A
Laura Dimichele-Vukovich
Exec. VP - Administrative Services, Human Resources
